Arjun Agarwal
Senior Vice President, Finance · Oruka Therapeutics, Inc.
- 2026
- Oct 13, 2026
- 10
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Arjun Agarwal files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Fairmount Funds Management LLC - $300.01M in ORKA purchases and sales in the last 12 months
- Lawrence Otto Klein - $9.40M in ORKA purchases and sales in the last 12 months
- Carl Dambkowski - $8.65M in ORKA purchases and sales in the last 12 months
- Paul T. Quinlan - $6.76M in ORKA purchases and sales in the last 12 months
- Joana Goncalves - $4.54M in ORKA purchases and sales in the last 12 months
- Laura Lee Sandler - $1.94M in ORKA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Arjun Agarwal?
Arjun Agarwal is a corporate insider, tracked as Senior Vice President, Finance of Oruka Therapeutics, Inc. (ORKA). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Arjun Agarwal submitted recently?
4 primary Form 4 filings in the last 90 days, covering 1 company.
Has Arjun Agarwal been buying or selling stock?
Recorded transactions: 0 open-market purchases and 30 open-market sales ($5.14M) across all tracked filings.
